Skip to main content

Table 1 Characteristics of patients with and without pemphigus

From: Pemphigus and pemphigoid are associated with Alzheimer’s disease in older adults: evidence from the US Nationwide inpatient sample 2016–2018

Characteristics

Before matching

After matching

Total

(n = 7,034,595)

With pemphigus

(n = 928)

Without pemphigus

(n = 7,033,667) a

p-value

Total

(n = 2700)

With pemphigus

(n = 900)

Without pemphigus

(n = 1800) a

p-value

AD

175,291 (2.5)

43 (4.6)

175,248 (2.5)

< 0.001

90 (3.3)

41 (4.6)

49 (2.7)

0.011

Age

73.9 ± 0.02

76.9 ± 0.30

73.9 ± 0.02

< 0.001

76.8 ± 0.2

77.0 ± 0.3

76.7 ± 0.2

0.425

 60–69

2,660,011 (37.8)

236 (25.4)

2,659,775 (37.8)

< 0.001

675 (25.0)

225 (25.0)

450 (25.0)

1.000

 70–79

2,310,666 (32.9)

298 (32.1)

2,310,368 (32.9)

 

864 (32.0)

288 (32.0)

576 (32.0)

 

 80+

2,063,918 (29.3)

394 (42.5)

2,063,524 (29.3)

 

1161 (43.0)

387 (43.0)

774 (43.0)

 

Sex

   

0.325

   

1.000

 Male

3,295,232 (46.8)

419 (45.2)

3,294,813 (46.8)

 

1215 (45.0)

405 (45.0)

810 (45.0)

 

 Female

3,739,363 (53.2)

509 (54.9)

3,738,854 (53.2)

 

1485 (55.0)

495 (55.0)

990 (55.0)

 

Race

   

< 0.001

   

1.000

 White

5,199,571 (76.3)

651 (72.3)

5,198,920 (76.3)

 

1953 (72.3)

651 (72.3)

1302 (72.3)

 

 Black

728,534 (10.7)

85 (9.4)

728,449 (10.7)

 

255 (9.4)

85 (9.4)

170 (9.4)

 

 Hispanic

530,188 (7.8)

86 (9.6)

530,102 (7.8)

 

258 (9.6)

86 (9.6)

172 (9.6)

 

 Others

356,397 (5.2)

78 (8.7)

356,319 (5.2)

 

234 (8.7)

78 (8.7)

156 (8.7)

 

 Missing

219,905

28

219,877

 

0

0

0

 

Household income

   

< 0.001

   

0.018

 Quartile1

1,942,389 (28.1)

213 (23.2)

1,942,176 (28.1)

 

679 (25.6)

206 (23.2)

473 (26.8)

 

 Quartile2

1,856,586 (26.8)

253 (27.6)

1,856,333 (26.8)

 

708 (26.7)

244 (27.4)

464 (26.3)

 

 Quartile3

1,684,484 (24.4)

214 (23.3)

1,684,270 (24.4)

 

655 (24.7)

206 (23.2)

449 (25.4)

 

 Quartile4

1,434,891 (20.7)

237 (25.9)

1,434,654 (20.7)

 

612 (23.1)

233 (26.2)

379 (21.5)

 

 Missing

116,245

11

116,234

 

46

11

35

 

Insurance status

   

< 0.001

   

0.120

 Medicare/Medicaid

5,778,056 (82.2)

821 (88.6)

5,777,235 (82.2)

 

2343 (86.8)

797 (88.7)

1546 (85.9)

 

 Private including HMO

1,016,340 (14.5)

89 (9.6)

1,016,251 (14.5)

 

293 (10.9)

85 (9.5)

208 (11.6)

 

 Self-pay/no-charge/other

232,118 (3.3)

17 (1.8)

232,101 (3.3)

 

62 (2.3)

17 (1.9)

45 (2.5)

 

 Missing

8081

1

8080

 

2

1

1

 

Active tobacco use

   

< 0.001

   

< 0.001

 No

4,428,686 (63.0)

675 (72.7)

4,428,011 (63.0)

 

1803 (66.8)

653 (72.6)

1150 (63.9)

 

 Yes

2,605,909 (37.0)

253 (27.3)

2,605,656 (37.1)

 

897 (33.2)

247 (27.4)

650 (36.1)

 

Excessive alcohol use

   

< 0.001

   

0.012

 No

6,784,456 (96.4)

916 (98.7)

6,783,540 (96.4)

 

2637 (97.7)

888 (98.7)

1749 (97.2)

 

 Yes

250,139 (3.6)

12 (1.3)

250,127 (3.6)

 

63 (2.3)

12 (1.3)

51 (2.8)

 

Chronic disease

        

 Ischemic heart disease

2,173,048 (30.9)

241 (26.0)

2,172,807 (30.9)

0.002

795 (29.4)

234 (26.0)

561 (31.2)

0.006

 Valvular heart disease

245,990 (3.5)

35 (3.8)

245,955 (3.5)

0.662

97 (3.6)

35 (3.9)

62 (3.4)

0.565

 DM

2,408,768 (34.2)

367 (39.6)

2,408,401 (34.2)

0.001

945 (35.0)

356 (39.6)

589 (32.7)

< 0.001

 Hypertension

5,282,711 (75.1)

684 (73.7)

5,282,027 (75.1)

0.326

2018 (74.7)

664 (73.8)

1354 (75.2)

0.402

 Dyslipidemia

3,231,935 (45.9)

391 (42.1)

3,231,544 (45.9)

0.026

1191 (44.1)

379 (42.1)

812 (45.1)

0.145

 Obesity

1,200,899 (17.1)

170 (18.3)

1,200,729 (17.1)

0.316

425 (15.7)

163 (18.1)

262 (14.6)

0.013

 Chronic pulmonary disease

2,051,208 (29.2)

207 (22.3)

2,051,001 (29.2)

< 0.001

735 (27.2)

200 (22.2)

535 (29.7)

< 0.001

 Severe liver disease

112,867 (1.6)

3 (0.3)

112,864 (1.6)

0.002

29 (1.1)

3 (0.3)

26 (1.4)

< 0.001

 Moderate to severe kidney disease

299,375 (4.3)

28 (3.0)

299,347 (4.3)

0.071

104 (3.9)

27 (3.0)

77 (4.3)

0.113

 Coagulopathy

517,828 (7.4)

89 (9.6)

517,739 (7.4)

0.010

229 (8.5)

87 (9.7)

142 (7.9)

0.116

 Peripheral vascular disease

726,322 (10.3)

77 (8.3)

726,245 (10.3)

0.048

271 (10.0)

76 (8.4)

195 (10.8)

0.048

 Atrial fibrillation

1,698,443 (24.1)

248 (26.7)

1,698,195 (24.1)

0.084

760 (28.1)

240 (26.7)

520 (28.9)

0.237

 Psychosis

105,568 (1.5)

13 (1.4)

105,555 (1.5)

0.836

36 (1.3)

13 (1.4)

23 (1.3)

0.755

 Depression

932,319 (13.3)

130 (14.0)

932,189 (13.3)

0.504

360 (13.3)

127 (14.1)

233 (12.9)

0.395

Systemic autoimmune disease

        

 SLE

27,637 (0.4)

7 (0.8)

27,630 (0.4)

0.078

12 (0.4)

7 (0.8)

5 (0.3)

0.058

 RA

186,468 (2.7)

36 (3.9)

186,432 (2.7)

0.027

79 (2.9)

34 (3.8)

45 (2.5)

0.058

 IBD

61,684 (0.9)

6 (0.7)

61,678 (0.9)

0.515

16 (0.6)

5 (0.6)

11 (0.6)

0.874

 SSc

9270 (0.1)

 

9270 (0.1)

 

3 (0.1)

0 (0.0)

3 (0.2)

 

 Sjogren’s syndrome

15,759 (0.2)

1 (0.1)

15,758 (0.2)

0.453

6 (0.2)

1 (0.1)

5 (0.3)

0.377

Other chronic inflammatory skin disease

        

 Atopic dermatitis

1359 (0.02)

1 (0.11)

1358 (0.02)

0.053

1 (0.0)

1 (0.1)

0 (0.0)

 

 Hidradenitis

1571 (0.02)

0 (0.00)

1571 (0.02)

 

2 (0.1)

0 (0.0)

2 (0.1)

 

 Dermatomyositis & polymyositis

3651 (0.1)

2 (0.2)

3649 (0.1)

0.029

2 (0.1)

2 (0.2)

0 (0.0)

 

 Psoriasis

43,822 (0.6)

12 (1.3)

43,810 (0.6)

0.009

19 (0.7)

11 (1.2)

8 (0.4)

0.010

 Alopecia areata

133 (0.0)

0 (0.0)

133 (0.0)

 

0 (0.0)

0 (0.0)

0 (0.0)

 

 Vitiligo

1815 (0.03)

0 (0.0)

1815 (0.03)

 

0 (0.0)

0 (0.0)

0 (0.0)

 

 Pyoderma gangrenosum

1272 (0.02)

2 (0.22)

1270 (0.02)

< 0.001

2 (0.1)

2 (0.2)

0 (0.0)

 

 Rosacea

6639 (0.1)

1 (0.1)

6638 (0.1)

0.894

2 (0.1)

1 (0.1)

1 (0.1)

0.479

Hospital bed size

   

0.278

   

0.081

 Large

3,415,536 (48.6)

476 (51.3)

3,415,060 (48.6)

 

1302 (48.2)

461 (51.2)

841 (46.7)

 

 Medium

2,083,258 (29.6)

259 (27.9)

2,082,999 (29.6)

 

817 (30.3)

253 (28.1)

564 (31.3)

 

 Small

1,535,801 (21.8)

193 (20.8)

1,535,608 (21.8)

 

581 (21.5)

186 (20.7)

395 (21.9)

 

Hospital location/teaching status

   

0.049

   

0.016

 Urban teaching

4,514,785 (64.2)

632 (68.1)

4,514,153 (64.2)

 

1760 (65.2)

616 (68.4)

1144 (63.6)

 

 Urban nonteaching

1,768,762 (25.1)

213 (23.0)

1,768,549 (25.1)

 

663 (24.6)

209 (23.2)

454 (25.2)

 

 Rural

751,048 (10.7)

83 (8.9)

750,965 (10.7)

 

277 (10.3)

75 (8.3)

202 (11.2)

 

Hospital region

   

< 0.001

   

0.019

 Northeast

1,383,332 (19.7)

238 (25.7)

1,383,094 (19.7)

 

629 (23.3)

237 (26.3)

392 (21.8)

 

 Midwest

1,581,671 (22.5)

184 (19.8)

1,581,487 (22.5)

 

517 (19.1)

165 (18.3)

352 (19.6)

 

 South

2,757,811 (39.2)

305 (32.9)

2,757,506 (39.2)

 

993 (36.8)

302 (33.6)

691 (38.4)

 

 West

1,311,781 (18.7)

201 (21.7)

1,311,580 (18.7)

 

561 (20.8)

196 (21.8)

365 (20.3)

 
  1. Continuous variables are presented as mean ± SE; categorical variables are presented as unweighted counts (weighted percentage). P-value < 0.05 are showed in bold
  2. Abbreviations: AD Alzheimer’s disease, DM diabetes mellitus, SLE systemic lupus erythematosus, RA rheumatoid arthritis, IBD inflammatory bowel disease, SSc systemic sclerosis
  3. a Excluded pemphigoid